CIK 0001818331 · Large accelerated filer
GeneDx Holdings Corp.
Sign in to watch- Ticker
- WGS
- Exchange
- Nasdaq
- Industry
- Services-Health Services
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851966622
- Phone
- 888-729-1206
- Business address
- 333 LUDLOW STREET, NORTH TOWER, 6TH FLOOR, STAMFORD, CT, 06902
- Former names
- Sema4 Holdings Corp., CM Life Sciences, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,839,245
- in 5 filings
Net −$1,839,245. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-18 | PFENNIGER RICHARD C JR Director | Option exercise · Restricted Stock Unit | −3,576 | 0 | ||
| 2026-06-18 | RUCH JOSHUA Director | Option exercise | +3,576 | 33,299 | ||
| 2026-06-18 | RUCH JOSHUA Director | Grant or award · Restricted Stock Unit | +4,248 | 4,248 | ||
| 2026-06-18 | RUCH JOSHUA Director | Option exercise · Restricted Stock Unit | −3,576 | 0 | ||
| 2026-06-16 | Feeley Kevin CHIEF FINANCIAL OFFICER | Option exercise | +7,197 | 43,683 | ||
| 2026-06-16 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale | −760 | $59.75 | $45K | 42,923 |
| 2026-06-16 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale | −2,106 | $60.83 | $128K | 40,817 |
| 2026-06-16 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale | −863 | $61.50 | $53K | 39,954 |
| 2026-06-16 | Feeley Kevin CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Unit | −7,197 | 21,590 | ||
| 2026-06-16 | Stueland Katherine CHIEF EXECUTIVE OFFICER | Option exercise | +18,750 | 114,873 | ||
| 2026-06-16 | Stueland Katherine CHIEF EXECUTIVE OFFICER | Sale | −2,140 | $59.75 | $128K | 112,733 |
| 2026-06-16 | Stueland Katherine CHIEF EXECUTIVE OFFICER | Sale | −5,932 | $60.83 | $361K | 106,801 |
| 2026-06-16 | Stueland Katherine CHIEF EXECUTIVE OFFICER | Sale | −2,429 | $61.50 | $149K | 104,372 |
| 2026-06-16 | Stueland Katherine CHIEF EXECUTIVE OFFICER | Option exercise · Restricted Stock Unit | −18,750 | 56,250 | ||
| 2026-06-09 | Feeley Kevin CHIEF FINANCIAL OFFICER | Option exercise | +2,462 | 37,752 | ||
| 2026-06-09 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale | −1,266 | $53.77 | $68K | 36,486 |
| 2026-06-09 | Feeley Kevin CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Unit | −2,462 | 4,925 | ||
| 2026-06-09 | Stueland Katherine CHIEF EXECUTIVE OFFICER | Option exercise | +6,546 | 99,762 | ||
| 2026-06-09 | Stueland Katherine CHIEF EXECUTIVE OFFICER | Sale | −3,639 | $53.77 | $196K | 96,123 |
| 2026-06-09 | Stueland Katherine CHIEF EXECUTIVE OFFICER | Option exercise · Restricted Stock Unit | −6,546 | 13,094 |
Page 3 of 23 · 450 trades